Andrulis Pharmaceuticals Corp.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Andrulis Pharmaceuticals Corp..The latest application filed is for "treatment of cancer with thalidomide alone or in combination with other anti-cancer agents".
- Andrulis Pharmaceuticals Corp. - Bethesda MD
- Andrulis Pharmaceuticals Corp. - Beltsville MD
| Patent | Date |
|---|---|
| Treatment of cancer with thalidomide alone or in combination with other anti-cancer agents Grant 6,140,346 - Andrulis, Jr. , et al. October 31, 2 | 2000-10-31 |
| Treatment of melanomas with thalidomide alone or in combination with other anti-melanoma agents Grant 5,731,325 - Andrulis, Jr. , et al. March 24, 1 | 1998-03-24 |
| Treatment of ischemia/reperfusion injury with thalidomide alone or in combination with other therapies Grant 5,643,915 - Andrulis, Jr. , et al. July 1, 1 | 1997-07-01 |
| Treatment of insulin resistant diabetes with thalidomine Grant 5,405,855 - Andrulis, Jr. April 11, 1 | 1995-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 